1.
J Med Chem
; 48(17): 5412-4, 2005 Aug 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16107139
RESUMO
The known KDR inhibitor SU5416 and several analogues of the indolin-2-one family were surprisingly found to be highly efficacious in the EAE model, an established model for multiple sclerosis. The high in vivo effect could be correlated to in vitro inhibition of the pro-inflammatory cytokine IL-2. Activity following po administration was obtained with several analogues and via the use of prodrugs.